What is Northland Capmk’s Estimate for Enovix Q1 Earnings?

Enovix Corporation (NASDAQ:ENVX) – Research analysts at Northland Capmk upped their Q1 2026 earnings per share estimates for shares of Enovix in a research note issued on Monday, November 17th. Northland Capmk analyst G. Richard now forecasts that the company will earn ($0.23) per share for the quarter, up from their previous estimate of ($0.24). The consensus estimate for Enovix’s current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix’s Q2 2026 earnings at ($0.23) EPS, Q4 2026 earnings at ($0.29) EPS and FY2026 earnings at ($1.06) EPS.

Enovix (NASDAQ:ENVX) last posted its quarterly earnings results on Tuesday, September 9th. The company reported ($0.13) earnings per share (EPS) for the quarter. The firm had revenue of $7.47 million for the quarter. Enovix had a negative return on equity of 61.78% and a negative net margin of 525.93%.

Other equities analysts also recently issued research reports about the company. Canaccord Genuity Group lowered their price target on Enovix from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Thursday, November 6th. JPMorgan Chase & Co. decreased their target price on Enovix from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Wednesday, November 12th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Enovix in a report on Friday, October 31st. Cantor Fitzgerald reduced their price objective on shares of Enovix from $30.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. Finally, Wall Street Zen lowered shares of Enovix from a “hold” rating to a “sell” rating in a research report on Saturday, September 6th. Five equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $17.50.

Enovix Stock Up 0.7%

Enovix stock opened at $7.50 on Wednesday. Enovix has a fifty-two week low of $5.27 and a fifty-two week high of $16.49. The firm has a market capitalization of $1.62 billion, a PE ratio of -9.26 and a beta of 2.09. The company’s 50-day moving average is $10.65 and its 200-day moving average is $10.33. The company has a debt-to-equity ratio of 1.74, a current ratio of 9.72 and a quick ratio of 9.47.

Hedge Funds Weigh In On Enovix

Several institutional investors and hedge funds have recently modified their holdings of ENVX. Millennium Management LLC increased its stake in Enovix by 1,038.9% during the 3rd quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock worth $14,724,000 after acquiring an additional 1,347,200 shares during the period. Kingstone Capital Partners Texas LLC acquired a new stake in shares of Enovix during the 2nd quarter worth $13,206,000. Two Sigma Investments LP increased its position in shares of Enovix by 9,197.1% in the third quarter. Two Sigma Investments LP now owns 1,200,997 shares of the company’s stock worth $11,974,000 after purchasing an additional 1,188,079 shares during the period. Electron Capital Partners LLC raised its stake in Enovix by 18.6% in the first quarter. Electron Capital Partners LLC now owns 6,712,763 shares of the company’s stock valued at $49,272,000 after purchasing an additional 1,054,029 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its position in Enovix by 1,852.4% during the third quarter. BNP Paribas Financial Markets now owns 835,553 shares of the company’s stock worth $8,330,000 after purchasing an additional 792,757 shares during the period. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Enovix news, COO Ajay Marathe sold 120,000 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $12.01, for a total transaction of $1,441,200.00. Following the transaction, the chief operating officer owned 1,027,259 shares in the company, valued at $12,337,380.59. This trade represents a 10.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 14.10% of the stock is currently owned by corporate insiders.

Enovix Company Profile

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.